Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Neurosciences|July 9, 2026
Phenotypic screening for small molecules that lower PrP in cultured cellsJeannine A Frei, Andrew G Reidenbach, Leo M H Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug developmentSonia M Vallabh, Chloe K Nobuhara, Franc Llorens, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Phenotypic screening for small molecules that lower PrP in cultured cellsJeannine A Frei, Andrew G Reidenbach, Leo Mh Xu, et al.
Molecular & Cellular Proteomics : MCP|September 28, 2019
Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass SpectrometryEric Vallabh Minikel, Eric Kuhn, Alexandra R Cocco, et al.
Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Biomarker changes preceding symptom onset in genetic prion diseaseSonia M Vallabh, Meredith A Mortberg, Shona W Allen, et al.
Neurology|February 27, 2020
Autoantibodies against the prion protein in individuals with PRNP mutationsKarl Frontzek, Manfredi Carta, Marco Losa, et al.
BMC Medicine|June 20, 2020
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion diseaseSonia M Vallabh, Eric Vallabh Minikel, Victoria J Williams, et al.
Science (New York, N.Y.)|June 27, 2024
Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editorEdwin N Neumann, Tessa M Bertozzi, Elaine Wu, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
PrP turnover in vivo and the time to effect of prion disease therapeuticsTaylor L Corridon, Jill O'Moore, Yuan Lian, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarkerJuliana E Gentile, Christina Heiss, Taylor L Corridon, et al.
Pageof 5